Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This will be an open-label, single-dose, non-randomized, five-period crossover study in
healthy volunteers. The duration of the study will last up to eleven weeks from screening to
follow-up. PK samples will be taken.